DRKS00005986
Recruiting
Not Applicable
Multicenter evaluation of MRI-targeted prostate biopsy
niversitätsklinikum Heidelberg0 sites509 target enrollmentMarch 18, 2014
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C61
- Sponsor
- niversitätsklinikum Heidelberg
- Enrollment
- 509
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Men referred for an initial prostate biopsy;
- •2\. PSA \> 3\.0 and \<50 ng/ml;
- •3\. No contraindications to mp\-MRI.
Exclusion Criteria
- •1\. Prior prostate biopsy;
- •2\. Highly suspicious prostate nodule on DRE;
- •3\. Contraindications to prostate biopsy;
- •4\. Known prostate cancer.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled StudyProstate CancerNCT05025527Shanghai East Hospital500
Completed
Not Applicable
Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. TransperinealProstate CancerNCT03650153Princess Al-Johara Al-Ibrahim Cancer Research Center165
Recruiting
Not Applicable
Focal therapy of prostate cancer using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technology: a prospective register study (FOXPRO_REGISTER)C61Malignant neoplasm of prostateDRKS00009021Klinik für Urologie, Universitätsmedizin Mannheim50
Recruiting
Not Applicable
Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory StudyProstate CancerNCT05612204GCS Ramsay Santé pour l'Enseignement et la Recherche50
Recruiting
Not Applicable
Efficacy of MRI-guided Prostate Irreversible Electroporation (IRE) therapy; the EMPIRE-trial.NL-OMON46509Sint Antonius Ziekenhuis40